Science Daily Reports on CBD Use in Glioblastoma Research Study

Science Daily recently reported positive outcomes in a Medicinal University of Georgia-Augusta University study that utilized CBD as a treatment for gliobastoma brain tumors. 

This study is the first of its kind to utilize inhalable CBD to treat gliobastoma brain tumors. Funded by 

Inhaled CBD shrinks the size of the highly aggressive, lethal brain tumor glioblastoma in an animal model by reducing the essential support of its microenvironment, researchers report.

Using modified glioblastoma cells from humans, they created what is called an orthotopic glioblastoma model, to provide a realistic model for this most common and lethal malignant brain tumor. By day eight the aggressive tumor was established in the brain of the mice, and at day 9 they started giving daily doses of inhaled CBD or a placebo that continued for seven days. They then looked again at an image of the tumor and directly at the tumor tissue.

It was the first study to use CBD in an animal model of glioblastoma, they report in the journal Cannabis and Cannabinoid Research.

Read the full study:

Dr. Martin Rutkowski, left, and Dr. Babak Baban